Two treatment strategy

[Mo Sh]

Hello,

My mother is diagnosed with RAEB-2 which was at march with 11% blast .. and became in this January 16%, took CYTRABINE as an alternative for DACOGEN because it wasn't available and her doctor was afraid of MDS is transormed to acute leukaemia . As a result for the 5 days cycle of CYTARABINE, her platlets count is always below 15000 in spite of the large amount of platlets transfused to her. That was three weeks ago and she's still the hospital since that time.

The hematologist who described this cure has an opinion that says that CYTARABINE will deeply influence her blast count and will reduce it to low level ... and when that happens he will be able to start DACOGEN again ( after platlets go up to around 30).

She made a bone marrow aspiration and we are waiting for result.

I took another experienced hematologist, and he said she should not start before count is about the 50000.

Which one do you think i should follow .. and Is This treatment strategy ok? or it's not logic that he gave her CYTARABINE with this large dose in this case, and he should have lower the dose a little bit until her main cure is arrived?